Plasma levels of fibrinolytic factors and TAFI in carriers of prothrombin G20210A mutation
Fibrinolytic factors and TAFI . | Noncarriers . | Carriers . |
|---|---|---|
| Plasminogen, % | 95.8 ± 12.2 | 93.3 ± 9.7 |
| α2-plasmin inhibitor, % | 102.0 ± 13.1 | 98.2 ± 11.8 |
| t-PA, ng/mL | 4.8 ± 2.6 | 5.1 ± 2.9 |
| PAI-1, U/mL | 15.7 ± 5.1 | 14.2 ± 4.6 |
| TAFI, μg/mL | 15.2 ± 8.3 | 14.8 ± 6.3 |
Fibrinolytic factors and TAFI . | Noncarriers . | Carriers . |
|---|---|---|
| Plasminogen, % | 95.8 ± 12.2 | 93.3 ± 9.7 |
| α2-plasmin inhibitor, % | 102.0 ± 13.1 | 98.2 ± 11.8 |
| t-PA, ng/mL | 4.8 ± 2.6 | 5.1 ± 2.9 |
| PAI-1, U/mL | 15.7 ± 5.1 | 14.2 ± 4.6 |
| TAFI, μg/mL | 15.2 ± 8.3 | 14.8 ± 6.3 |
For noncarriers, n = 30; for carriers, n = 32.